SCOTTGOTTLIEB.COMUpdate (May 9): The US Senate has confirmed Gottlieb as the next FDA commissioner.
Update (March 30): In a letter to the associate general counsel for ethics at the US Department of Health and Human Services dated this week (March 28), Scott Gottlieb outlined his plan for addressing the numerous conflicts of interest he would face if confirmed to lead the FDA. For one year, Gottlieb would recuse himself from FDA decisions pertaining to the nearly two dozen health-care companies he’s worked with, according to The New York Times. In addition, he plans to resign from “his roles in investment banking, venture capital, and as a consultant to drug companies within 90 days of his Senate confirmation,” STAT News reported, and “sell off his shares in a host of biotech companies.” —The Scientist staff
Scott Gottlieb was on Friday ...